Adipotide

Adipotide is a peptidomimetic engineered to target the vasculature that supplies white adipose tissue. It is described as binding prohibitin-1 on adipose endothelial cells and then delivering a pro-apoptotic sequence that damages those targeted blood vessels. With reduced perfusion, adipocytes are deprived of oxygen and nutrients, which can drive fat-cell apoptosis and subsequent clearance through normal metabolic pathways. In preclinical obesity models, this vascular-targeting concept produced measurable body-weight reduction over short treatment windows, including notable effects in rodent and primate studies. However, the compound’s development history is also closely tied to safety limitations: higher exposures were associated with reversible renal toxicity in prior research, and clinical development was discontinued. As a result, discussion of Adipotide typically emphasizes its mechanistic specificity alongside a cautious interpretation of risk and limited human evidence.